Xiamen Innovax Launches World’s First Hepatitis E Vaccine
Xiamen Innovax Biotech confirmed it has launched Hecolin, the world's first hepatitis E vaccine, in the China market. The SFDA approved the vaccine in January of this year. According to Innovax, the government is cooperating in an effort to offer the vaccine to high-risk individuals in China. More details.... Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here